  The paraclinical examinations , principally the MRI have an increasing significance in the diagnosis of multiple sclerosis. However , MRI markers also have a prominent role in monitoring of the disease-course and activity , and also in the planning of possible therapeutic changes. In accordance with previously published international guidelines , in this article we propose a protocol for the monitoring the treatment efficacy in multiple sclerosis. This could be the basis of a consensus based guideline to be implemented in Hungary.